What is the average price target for CORTEVA INC (CTVA) stock?
30 analysts have analysed CTVA and the average price target is 84.83 USD. This implies a price increase of 1.19% is expected in the next year compared to the current price of 83.83.
NYSE:CTVA • US22052L1044
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORTEVA INC (CTVA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-09 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-31 | Argus Research | Maintains | Buy -> Buy |
| 2026-02-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-05 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2026-02-05 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-01-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-21 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-16 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-18 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-30 | UBS | Maintains | Buy -> Buy |
| 2025-10-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-13 | Argus Research | Maintains | Buy -> Buy |
| 2025-10-08 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-03 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-10-02 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-02 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-08-13 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-08-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-08-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-07 | UBS | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.226B -1.31% | 16.908B -1.85% | 17.401B 2.92% | 18.457B 6.07% | 19.027B 3.09% | 19.556B 2.78% | 19.742B 0.95% | 20.305B 2.85% | 20.812B 2.50% | 21.281B 2.25% | 21.76B 2.25% | |
| EBITDA YoY % growth | 3.321B 5.40% | 3.323B 0.06% | 3.822B 15.02% | 4.217B 10.33% | 4.491B 6.50% | 4.806B 7.01% | 4.681B -2.60% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 2.11B 9.44% | 2.096B -0.66% | 2.619B 24.95% | 3.386B 29.29% | 3.573B 5.52% | 3.84B 7.47% | 3.66B -4.69% | 3.335B -8.88% | 3.38B 1.35% | 3.417B 1.09% | 3.454B 1.08% | |
| Operating Margin | 12.25% | 12.40% | 15.05% | 18.35% | 18.78% | 19.64% | 18.54% | 16.42% | 16.24% | 16.06% | 15.87% | |
| EPS YoY % growth | 2.68 1.13% | 2.55 -4.85% | 3.32 30.20% | 3.72 11.99% | 4.09 9.94% | 4.54 11.17% | 4.35 -4.38% | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.20 5.86% | 2.36 7.48% | -0.26 -12.23% | 0.37 68.39% | 1.27 6.52% | 2.54 7.35% | -0.31 -21.81% | 0.47 25.55% | 1.45 13.67% | 2.73 7.70% | -0.36 -13.54% | 0.43 -7.89% |
| Revenue Q2Q % growth | 4.739B 7.29% | 6.802B 5.36% | 2.697B 3.02% | 4.209B 7.65% | 4.864B 2.64% | 6.945B 2.10% | 2.711B 0.52% | 4.256B 1.12% | 5.091B 4.67% | 7.227B 4.06% | 2.776B 2.40% | 4.514B 6.06% |
| EBITDA Q2Q % growth | 1.286B 14.51% | 2.311B -4.86% | 35.077M -94.46% | 572.24M -59.90% | 1.375B 6.92% | 2.448B 5.93% | -6.831M -119.47% | 654.43M 14.36% | 1.488B 8.22% | 2.54B 3.76% | 10.904M 259.63% | 621.77M -4.99% |
| EBIT Q2Q % growth | 1.065B 28.78% | 2.058B 12.34% | -161.283M 38.91% | 382.56M 70.79% | 1.209B 13.52% | 2.171B 5.49% | -168.983M -4.77% | 384.45M 0.49% | 1.291B 6.78% | 2.344B 7.97% | -185.762M -9.93% | 425.11M 10.58% |
All data in USD
30 analysts have analysed CTVA and the average price target is 84.83 USD. This implies a price increase of 1.19% is expected in the next year compared to the current price of 83.83.
CORTEVA INC (CTVA) will report earnings on 2026-05-05, after the market close.
The consensus EPS estimate for the next earnings of CORTEVA INC (CTVA) is 1.2 USD and the consensus revenue estimate is 4.74B USD.
The consensus rating for CORTEVA INC (CTVA) is 79.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.